Health Canada
Symbol of the Government of Canada
Environmental and Workplace Health

Guidelines for the Safe Use of Diagnostic Ultrasound - Glossary of Terms

6. Glossary of Terms

ALARA (As Low As Reasonably Achievable): a principle which is used to reduce unnecessary, potentially hazardous exposure to individuals, by keeping doses As Low As Reasonably Achievable.

As shown throughout this guideline, application of the ALARA principle to diagnostic ultrasound differs from its common usage in diagnostic X-ray imaging where it is assumed that there is no threshold exposure.

In the use of diagnostic ultrasound, there are three ranges of exposure, i.e., combinations of Thermal or Mechanical Indices and dwell time, that need to be considered. At exposures that are clearly below the thresholds for health effects, further reduction of exposure is not justified, whether it is via reductions in dwell time or acoustic output. There can also be exposures that are or may be above thresholds for health effects. In these cases, ALARA refers to using the lowest value of potentially hazardous exposure, i.e. combination of acoustic output and dwell time, needed to achieve the required diagnostic information.

Bone Thermal Index (TIB): the Thermal Index for an exposure model in which the ultrasound beam passes through soft tissue and a focal region is in the immediate vicinity of bone.

Cranial Bone Thermal Index (TIC): the Thermal Index for an exposure condition in which the ultrasound beam passes through bone near the beam entrance into the body.

derated: a derated quantity is one which has been measured in water using standard methods and then multiplied by a derating factor. This accounts for attenuation of the ultrasound field by the tissue between the transducer and a particular location in the body along the beam axis. The derating factor is 0.3 dB/cm-MHz in these guidelines.

derated spatial peak time average intensity: the largest value in an ultrasound beam of any derated time averaged intensity.

dwell time: the amount of time that the transducer is actively transmitting ultrasound while staying in one place during part of an examination.

rarefactional pressure: the amplitude of a negative instantaneous ultrasonic pressure in an ultrasound beam

Soft Tissue Thermal Index (TIS): the Thermal Index for an exposure model in which the ultrasound beam heats primarily soft tissue.

spatial average, pulse average intensity at the face of the transducer: the spatial average,temporal average intensity at the face of the transducer divided by the duty factor, where the duty factor is the product of the pulse duration and the pulse repetition frequency.

spatial average, temporal average intensity at the face of the transducer: the time averaged intensity, averaged over the face of the transducer.

Thermal Index (TI): a quantity related to the potential for ultrasonic heating. It is proportional to a calculated or estimated temperature rise for model exposure conditions. The Thermal Index is given by the ratio of the ultrasonic power emitted by the transducer to the ultrasonic power required to raise tissue temperature by 1 °C for the model exposure conditions. In the calculation of all Thermal Indices, the average ultrasonic attenuation in the body is assumed to be 0.3 dB/cm-MHz along the beam axis (e.g., the ultrasonic intensity is reduced by 3 dB, a factor of 2, for a 5 MHz beam, 2 cm into the body along the beam axis.)

Mechanical Index (MI): a quantity related to the potential for mechanical effects during a diagnostic ultrasound examination. It is given by the ratio of the largest value in the ultrasound beam of any derated rarefactional pressure to the square root of the transducer frequency. The pressure is in Megapascals and the frequency is in MHz.

U.S. FDA 510(k) guidance document: a document prepared by and available from the Centre for Devices and Radiological Health, U.S. Food and Drug Administration, which provides information for manufacturers seeking U.S.marketing clearance of diagnostic ultrasound systems and transducers. It is intended to provide guidance in the preparation of a regulatory submission to the U.S. FDA and does not bind the FDA or the regulated industry in any manner.

ultrasonic heating: the heating of tissue (including bone) due to the absorption of ultrasound.

ultrasonic power: the total amount of ultrasound energy emitted by the transducer per unit time.